Viral envelope protein 53R gene highly specific silencing and iridovirus resistance in fish Cells by AmiRNA

Yu-Sin Kim1, Fei Ke, Xiao-Ying Lei

  • 1State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.

Plos One
|April 30, 2010
PubMed
Abstract

Insights

This study introduces artificial microRNAs (amiRNAs) to silence the frog virus Rana grylio virus (RGV) envelope protein 53R in fish cells. This novel approach effectively inhibits RGV infection and virion assembly, offering a new strategy for antiviral resistance.

Area of Science:

  • Virology
  • Molecular Biology
  • Biotechnology

Background:

  • The frog virus Rana grylio virus (RGV) is an aquatic animal pathogen.
  • The RGV envelope protein 53R is crucial for virus assembly.
  • RNA interference (RNAi) has not been previously reported for inhibiting aquatic animal virus envelope proteins.

Purpose of the Study:

  • To develop artificial microRNAs (amiRNAs) targeting the RGV 53R envelope protein gene.
  • To investigate the efficacy of amiRNAs in inhibiting RGV replication and virion assembly in fish cells.
  • To establish a novel RNAi-based antiviral strategy for aquatic animals.

Main Methods:

  • Artificial microRNAs (amiRNAs) targeting RGV 53R were designed and incorporated into pre-miRNA155 vectors.
  • These vectors were transfected into fish cell lines to express amiRNAs (amiR-53Rs).
  • RGV 53R expression, viral load, and virion assembly were analyzed using real-time PCR and electron microscopy.

Main Results:

  • The amiRNA amiR-53R-1 effectively silenced the RGV 53R gene expression.
  • Viral infection was suppressed by 58% with amiR-53R-1 targeting a specific region of RGV 53R.
  • Electron microscopy confirmed defects or reduced capacity in virion assembly correlated with amiR-53R-1 expression.

Conclusions:

  • This study presents the first report of an amiRNA targeting an iridovirus envelope protein gene.
  • amiR-53R-1 demonstrates significant potential for inhibiting RGV infection and virion assembly in fish.
  • This research establishes a foundation for developing RNAi-based antiviral therapies for aquatic viral diseases.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...